- Home
- ESPR vs WRN Comparison
ESPR vs WRN Comparison
Compare ESPR & WRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESPR
- WRN
- Stock Information
- Founded
- ESPR 2008
- WRN 2006
- Country
- ESPR United States
- WRN Canada
- Employees
- ESPR N/A
- WRN N/A
- Industry
- ESPR Biotechnology: Pharmaceutical Preparations
- WRN Metal Mining
- Sector
- ESPR Health Care
- WRN Basic Materials
- Exchange
- ESPR Nasdaq
- WRN Nasdaq
- Market Cap
- ESPR 208.1M
- WRN 226.0M
- IPO Year
- ESPR 2013
- WRN N/A
- Fundamental
- Price
- ESPR $0.85
- WRN $1.14
- Analyst Decision
- ESPR Buy
- WRN Strong Buy
- Analyst Count
- ESPR 7
- WRN 1
- Target Price
- ESPR $5.93
- WRN $4.25
- AVG Volume (30 Days)
- ESPR 6.2M
- WRN 540.4K
- Earning Date
- ESPR 05-06-2025
- WRN 05-09-2025
- Dividend Yield
- ESPR N/A
- WRN N/A
- EPS Growth
- ESPR N/A
- WRN N/A
- EPS
- ESPR N/A
- WRN N/A
- Revenue
- ESPR $259,574,000.00
- WRN N/A
- Revenue This Year
- ESPR $4.07
- WRN N/A
- Revenue Next Year
- ESPR N/A
- WRN N/A
- P/E Ratio
- ESPR N/A
- WRN N/A
- Revenue Growth
- ESPR 12.99
- WRN N/A
- 52 Week Low
- ESPR $0.69
- WRN $0.90
- 52 Week High
- ESPR $3.94
- WRN $1.36
- Technical
- Relative Strength Index (RSI)
- ESPR 44.65
- WRN 50.54
- Support Level
- ESPR $0.79
- WRN $1.02
- Resistance Level
- ESPR $0.88
- WRN $1.27
- Average True Range (ATR)
- ESPR 0.07
- WRN 0.06
- MACD
- ESPR 0.02
- WRN 0.00
- Stochastic Oscillator
- ESPR 69.48
- WRN 48.00
About ESPR Esperion Therapeutics Inc.
Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.
About WRN Western Copper and Gold Corporation
Western Copper & Gold Corp is a Canada-based exploration-stage company. The company is engaged in the exploration and development of the Casino mineral property located in Yukon, Canada (the Casino Project).